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Introduction
Acute transverse myelitis (ATM) is an acute or subacute
spinal cord dysfunction characterised by paraplegia, a
horizontal level of sensory impairment and sphincter dys-
function in which secondary causes such as compressive
lesions, tuberculosis, syphilis, arteriovenous malforma-
tion, trauma and malignant infiltration have been ex-
cluded [4]. ATM has a uniform clinical picture, but its
course is variable and prognosis difficult to predict. There
have been few studies of the prognosis of ATM. In one
study good, fair and poor outcomes were reported in one-
third of the patients each [3]. In another study of 52 pa-
tients with transverse myelitis, those with an acute onset
of symptoms had a poor prognosis [11]. Pain in the mid-
thoracic region has also been regarded as a poor prognos-
tic predictor [1]. ATM may follow an infection or vacci-
nation, but a number of patients remain in the idiopathic
group. On follow-up, 3–13.5% of patients presenting as
ATM develop multiple sclerosis (MS) [7, 11]. The prog-
nosis of ATM associated with MS is better than that of the
parainfectious group. The patients with idiopathic trans-
verse myelitis, however, had an unpredictable course and
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outcome. The endpoint in the study by Jeffery et al. [5]
was defined at a variable time, ranging between 1 month
and 30 years. EMG changes in ATM have been reported,
but their clinical significance has not been highlighted [3].
In a recent report on ten patients with ATM, the extent of
signal changes on spinal cord magnetic resonance imag-
ing (MRI), unrecordable motor evoked potentials (MEPs)
(especially on lumbar stimulation) and EMG changes
were associated with poor outcome [9]. In the present
study, we report the EMG changes in patients with ATM
and their prognostic significance.
Patients and methods
Consecutive patients with ATM based on the following criteria
were included [5]: (1) acutely or subacutely developing motor sen-
sory and sphincter disturbance, (2) spinal segmental level of sen-
sory disturbance with a well-defined upper limit, (3) no clinical or
laboratory evidence of spinal cord compression, (4) absence of
other known neurological diseases such as syphilis, previously di-
agnosed MS, neoplasm, spinal cord arteriovenous malformation,
sarcoidosis or HIV infection, (5) lack of clinical progression be-
yond 4 weeks.
A detailed medical history was taken, and physical examina-
tion was carried out. Muscle weakness was assessed by the Med-
ical Research Council (MRC) scale and muscle tone by the Ash-
worth scale. Tendon reflexes, plantar responses, pinprick, joint po-
sition and vibration sensation were also tested. Cerebrospinal fluid
(CSF) was examined for cells, protein and sugar. Full blood
counts, urinalysis, erythrocyte sedimentation rate (ESR), blood
sugar, serum creatinine, serum protein, serum electrolytes, collagen
profile (antinuclear antibodies, anti-double-stranded (ds) DNA and
rheumatoid factors), serum test for syphilis and HIV were carried
out in all patients, and those with abnormal findings were ex-
cluded.
Spinal MRI or myelography was carried out in all patients. For
spinal MRI, a 2.0-T superconducting system operating at 1.5 T us-
ing a flat oval surface coil was used. In three patients, MRI was
carried out on a 0.5-T scanner. The entire spinal cord was imaged
and T1-[500/15/3 (TR in ms/TE in ms/excitations)], proton den-
sity-(2000–2400/15–20/1) and T2-weighted (2200–2500/80–90/1)
SE images were obtained in sagittal plain with slice thickness of
0.3 mm and 256 · 256 matrix.
Concentric needle EMG was carried out in all patients after
2–3 weeks from onset. Tibialis anterior, gastrocnemius, vastus
medialis, biceps femoris, paraspinal, first dorsal interosseous, bra-
chioradialis, biceps brachii and deltoid muscles were examined
and selected on the basis of the clinical motor loss. Spontaneous
activity, MUPs (duration, shape and amplitude) and interference
pattern were evaluated. Fibrillations and sharp waves were classi-
fied from 0 to 4+ : 0 = none, + = persistent single train in at least
two areas, 2+ = moderate number of fibrillations in 3 or more ar-
eas, 3+ = many in all areas, 4+ = filling the baseline in all areas
[2]. For spontaneous activity a gain of 50 m V/division and for
MUPs a gain of 200 m V/division with a sweep speed of 10 ms/di-
vision and filter setting 2Hz–10KHz were used. Peroneal and
sural nerve conductions were also measured using the standard
techniques [6].
The clinical examination and EMG studies were repeated 3
months after the onset of illness. The outcome was defined as poor
or good recovery on the basis of the 3-month Barthel index score.
A score of 12 or more was defined as good and below 12 as poor
outcome [9]. The relationship between various clinical and EMG
variables with outcome was evaluated by chi-square test.
Results
During 1993 and 1996, there were 26 patients with trans-
verse myelopathy; these inlcuded 2 with ischaemic
myelopathy, 3 with MS and 1 with herpes simplex virus I
(HSV-I) myelitis in a patient with AIDS. The remaining
19 patients had idiopathic ATM. Two of these patients
had a fulminant course and died from respiratory paraly-
sis in the 1st week of illness. Detailed MRI and EMG ex-
amination in these patients was not possible. The present
study is based on 17 patients with ATM. The mean age of
these patients was 31.5 years (range 14–70), and 3 were
female. Eight patients had a history of fever preceding
their illness, and backache was present in 2. The illness
peaked by 6 days (range 1–30). All patients had an acute
onset of paraplegia, sensory impairment and bladder dys-
function. Muscle wasting was present in 11 patients in the
lower limbs and in 1 in the small muscles of the hands as
well. The wasting was noted by 3–4 weeks. All patients
had complete paraplegia (MRC grade 0), except 1 who
had grade III power in the lower limbs. Six patients had
upper limb weakness, but it was less pronounced than
that in the lower limbs. The upper limb power ranged be-
tween grade II and IV being grade II and grade III in 1
patient each, whereas in the remaining patients it was
grade IV. On admission, the lower limbs were flaccid in
13, spastic in 3 and tone was normal in 1 patient. Spastic-
ity in the upper limbs was present in 2 patients only. Knee
and ankle reflexes were diminished in 12 and exagger-
ated in 5 patients. Upper limb reflexes were normal in 7
patients, increased in 9 and reduced in 2. Six of the pa-
tients with upper-limb reflex abnormalities also had asso-
ciated weakness. The sensory loss for touch and pinprick
was present in mid-thoracic level (D5-D8) in 8, upper
thoracic level (D1-D4) in 4, lower thoracic region in 4
and lumbar region in 1 patient. All patients had impaired
joint position sensation in the lower limbs and retention
of urine.
CSF was abnormal in all patients. Mean CSF protein
was 190.6 mg/dl (range 18–495), mean cell count was
59/mm3 (range 4–310), mainly lymphocytes. Mean CSF
sugar was 66.5 mg/dl (range 36–108). MRI was carried
out in 14 patients and was abnormal in all except 2. The
MRI abnormalities included hypo- to iso-intense signal
changes in T1 and hyperintense in T2 in all except 1 who
had hyperintense lesions in both T1 and T2, suggestive of
haemorrhagic myelitis. The extent of signal changes
ranged from normal MRI (2 patients in whom it was car-
ried out on a 0.5-T scanner) to extensive signal changes
beyond the sensory level by a mean of 8.5 spinal seg-
ments (range 2–18). The relationship between the extent
of MRI signal changes (more than 10 segments) with tone
(c 2 = 0.36, df = 1, NS) and outcome (c 2 = 0.04, df = 1,
NS) was not found to be significant. Myelography, carried
out in 3 patients in whom MRI was not possible, was nor-
mal.
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Concentric needle EMG was carried out at least
2 weeks after the onset of weakness. It revealed fibrilla-
tions and sharp waves in 11 patients in the lower limb
muscles. The severity of fibrillations ranged between 2+
and 4+. The MUPs were not recordable in 5 and were of
normal to short duration with reduced recruitment in the
remaining patients. Upper limb EMG was normal in all
except 3 patients. Upper limb denervation changes on EMG
were present in 3 patients, but did not correlate with MRI
signal changes in the cervical spinal cord (c 2 = 0.82, 
df = 1, NS). Sural nerve conduction velocity and ampli-
tude of sensory nerve action potential were normal in all
except 1 patient in whom sural nerve conduction was un-
recordable. This patient, however, had pronounced leg
oedema. Peroneal nerve conduction velocity was normal
in 10 and was not recordable in the remaining patients. 
All patients were followed up at 3 months after the ill-
ness. The lower limb power improved from initial grade 0
in 7 and grade II in 1 patient. The mean improvement was
3.5 MRC grades (range II–IV). Upper limb power also be-
came normal in 5 patients, and in 1 it improved from
grade II to grade III. Initially flaccid lower limbs became
spastic in 2 patients; however, in 8 patients the lower
limbs were persistently hypotonic. Sensation improved in
4 patients. EMG 3 months after the onset of illness re-
vealed absence of spontaneous activity in 6 patients, and
the MUPS were of long duration, polyphasic with poor re-
cruitment. In 5 patients, fibrillations and sharp waves
recorded even at 3 months, and the MUPS were unrecord-
able. Six patients had a good and 11 had a poor recovery.
The clinical features and EMG changes in ATM patients
are shown in Table 1. Hypotonia (c 2 = 6.24, df = 1, 
P < 0.01) and EMG changes (c 2 = 12.90, df = 1, 
P < 0.00001) were significantly related to the 3-month
outcome, whereas the rapidity of onset, age, upper limb
weakness, severity of paraplegia and backache were not.
The EMG changes were present in 11 patients, and all of
them had a poor outcome. All 6 patients without EMG ab-
normality had a good outcome. Eleven of 13 patients with
hypotonia had a poor outcome whereas those without hy-
potonia recovered well.
Discussion
In our study, all patients with EMG changes suggestive of
denervation had a poor outcome, whereas those without
such changes recovered well. In ATM, the histopatholog-
ical changes include varying proportions of oedema, de-
myelination and necrosis involving both the white and
grey matter of the spinal cord. The EMG findings of den-
ervation in the presence of normal sensory nerve conduc-
tion studies are likely to be owing to anterior horn cell in-
volvement. In ATM, anterior horn cell involvement may
suggest more severe and widespread involvement of the
spinal cord with a poor chance of recovery. In myelitis,
the polar forms include anterior horn cell involvement in
poliomyelitis, dorsal root ganglia in herpes zoster and
white matter in MS. In ATM, both grey and white matter
may be involved to a varying degree. The ATM patients
with predominantly white matter changes are likely to im-
prove better and earlier compared with those with anterior
horn cell involvement. The recovery following demyeli-
nation depends upon the improvement in conduction
block and subsequent remyelination. The compensation
following anterior horn cell damage depends upon axonal
sprouting, which is so effective that up to 50% of the orig-
inal number of anterior horn cells may be lost without any
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Table 1 Clinical features,
EMG change and outcome in
patients with acute transverse
myelitis (P paraplegia, Q quad-
riplegia)
a Dorsal pain
b + = present, – = absent
No. Age/sex Onset Weakness Hypotoniab Sensory Fibrillations Outcome
(years) to peak level on initial 
(day) examinationsb
1 14/M 2 P + D6 + Poor
2 22/M 4 P – D8 – Good
3 45/M 1 Q + D8 + Poor
4 57/M 14 P + L1 + Poor
5 15/M 1 Q + D4 + Poor
6 15/F 1 P + D4 + Poor
7 36/M 2 P + D4 + Poor
8 17/M 15 P – D9 – Good
9 25/M 1 P – D8 – Good
10 52/F 2 Q + D2 + Poor
11 40/M 1 Q + D10 – Good
12a 16/M 5 Q + D7 + Poor
13 33/M 1 Q – D7 – Good
14 20/F 15 P + D10 + Poor
15 14/M 3 P – D8 – Good
16 45/M 4 P + D8 + Poor
17 70/M 30 P + D10 + Poor
clinical weakness [12]. Weakness and denervation on
EMG may be owing to extensive involvement of anterior
horn cells. The importance of the anterior horn cells was
highlighted in an earlier study in which MS patients pre-
senting as myelitis improved better than those with
parainfectious and idiopathic ATM. Anterior horn cells
may be involved in the latter, but not in MS patients. The
presence of backache in the thoracic region has been re-
ported to predict a poor outcome in ATM [1, 11]. In our
study, only two patients had backache and both had a poor
outcome; however, nine of our patients without any back-
ache also had a poor outcome. Repidity of onset weakness
has also been reported to be a preditor of poor prognosis,
but this was not so in our study. MS patients presenting as
ATM are likely to have a slower onset of illness and a bet-
ter short-term outcome. A history of preceding fever be-
fore the onset of ATM (parainfectious group) has also
been regarded as a poor predictor [5]. In our study, the
outcome of the patients with and without preceding fever
did not significantly differ. The two important prognostic
predictors in our study, hypotonia and features of dener-
vation on EMG, may be interrelated. Initial hypotonia
may be owing to anterior horn cell involvement and spinal
shock. In a number of our patients, it was replaced by
spasticity as the stage of spinal shock passed off. A criti-
cal mass of anterior horn cells is necessary for the spastic-
ity to manifest. Weakness, wasting and hypotonia mani-
fest when the anterior horn cell population decreases to
10% or less. Five of our patients had persistent flaccidity,
areflexia, and the EMG changes of denervation persisted
even after 3 months, suggesting pronounced anterior horn
cell involvement. In the remaining patients, repeat EMG
revealed reduction of denervation and appearence of long-
duration polyphasic potentials, suggesting reinnervation.
The recruitment pattern, however, was markedly reduced,
which may not only be owing to anterior horn cell loss,
but also to associated spasticity.
The EMG change in ATM may be analogous to po-
liomyelitis in which the severity of weakness and out-
come may correlate with EMG change [10]. Anterior horn
cells are the final pathway, and their involvement is criti-
cal for motor deficits, even if the white matter changes are
mild. In ATM, unrecordable MEPs, especially on spinal
stimulation, were associated with poor outcome in our
earlier study [9]. Profound loss of anterior horn cells may
result in unrecordable MEPs on cortical or spinal stimula-
tion. In some patients with anterior horn cell disease,
however, marginal prolongation of central motor conduc-
tion times with reduced amplitude of MEP’s has also been
reported [8, 9]. Some patients who present as ATM may
develop further neurological signs and turn out to have
MS (3–13.5% of patients) [7, 10], although others regard
this as an extremely rare possibility [5]. In our patients,
the clinical and MRI features were not suggestive of MS.
During this periord, only two patients with MS presented
as ATM, and they have not been included in this study.
The EMG features of anterior horn cell involvement may
provide additional evidence against MS.
It can be conlcuded from our study that the EMG
changes in ATM may provide valuable information about
its prognosis. EMG, being an easily available, cheap and
simple investigation, may have wider applications in the
diagnosis and prognosis of the patients presenting as acute
transverse myelitis.
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